Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial
Publication
, Conference
Richardson, PG; Kernan, NA; Brochstein, JA; Mineishi, S; Arai, S; Grupp, SA; Guinan, E; Martin, PL; Steinbach, G; Krishnan, A; Nemecek, ER ...
Published in: Biology of Blood and Marrow Transplantation
March 2016
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
March 2016
Volume
22
Issue
3
Start / End Page
S25 / S25
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Richardson, P. G., Kernan, N. A., Brochstein, J. A., Mineishi, S., Arai, S., Grupp, S. A., … Soiffer, R. J. (2016). Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial. In Biology of Blood and Marrow Transplantation (Vol. 22, pp. S25–S25). Elsevier BV. https://doi.org/10.1016/j.bbmt.2015.11.306
Richardson, Paul G., Nancy A. Kernan, Joel A. Brochstein, Shin Mineishi, Sally Arai, Stephan A. Grupp, Eva Guinan, et al. “Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial.” In Biology of Blood and Marrow Transplantation, 22:S25–S25. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.306.
Richardson PG, Kernan NA, Brochstein JA, Mineishi S, Arai S, Grupp SA, et al. Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2016. p. S25–S25.
Richardson, Paul G., et al. “Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial.” Biology of Blood and Marrow Transplantation, vol. 22, no. 3, Elsevier BV, 2016, pp. S25–S25. Crossref, doi:10.1016/j.bbmt.2015.11.306.
Richardson PG, Kernan NA, Brochstein JA, Mineishi S, Arai S, Grupp SA, Guinan E, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Duerst RE, Antin JH, Lehmann L, Gillio AP, Bajwa R, Miloslavsky M, Hume R, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial. Biology of Blood and Marrow Transplantation. Elsevier BV; 2016. p. S25–S25.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
March 2016
Volume
22
Issue
3
Start / End Page
S25 / S25
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences